Lapatiniblet and pericardial effusion malignant Patient Reports February 13, 2012

Lapatiniblet Side Effects Report #5640116-5
Lapatiniblet side effect was reported by a Physician from AUSTRIA on Feb 11, 2008. Female patient, 55 years of age, weighting 173.1 lb, was diagnosed with breast cancer metastatic and was treated with Lapatiniblet. After drug was administered, patient experienced the following side effects: disease progression, pericardial effusion malignant. Lapatiniblet dosage: unknown. During the same period patient was treated with CAPECITABINELET. Patient was hospitalized. Patient recovered.